SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-021613
Filing Date
2024-02-13
Accepted
2024-02-13 17:10:49
Documents
2
Group Members
MARK ANGELOYA GLOBAL INVESTMENTS II (U.S.), LPYA II GP, LPYAII GP II, LLCYORKVILLE ADVISORS GLOBAL II, LLCYORKVILLE ADVISORS GLOBAL, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm246129d2_sc13ga.htm SC 13G/A 131866
2 EXHIBIT 99.1 tm246129d2_ex99-1.htm EX-99.1 23287
  Complete submission text file 0001104659-24-021613.txt   157128
Mailing Address 101 HUDSON STREET #3700 JERSEY CITY NJ 07302
Business Address 101 HUDSON STREET #3700 JERSEY CITY NJ 07302 201 985 8300
YA II PN, Ltd. (Filed by) CIK: 0001463928 (see all company filings)

IRS No.: 980615492 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 631 US HWY 1, SUITE 407 NORTH PALM BEACH FL 33408
Business Address 631 US HWY 1, SUITE 407 NORTH PALM BEACH FL 33408 612-961-5656
Nascent Biotech Inc. (Subject) CIK: 0001622057 (see all company filings)

IRS No.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-92600 | Film No.: 24629163
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)